Autologous patient-derived organoid-immune cell co-culture platform for therapeutics discovery in high-grade endometrial cancer

被引：0
|
作者：
Chung, Charlie
Nizam, Aaron
Yueh, Brian
Subhash, Santhilal
Frimer, Marina
Goldberg, Gary L.
Beyaz, Semir
机构：
来源：
CLINICAL CANCER RESEARCH | 2024年 / 30卷 / 05期
关键词：
D O I：
10.1158/1557-3265.ENDO24-A019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A019
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Establishment of a 3D Co-culture With MDA-MB-231 Breast Cancer Cell Line and Patient-Derived Immune Cells for Application in the Development of Immunotherapies
    Saraiva, Diana P.
    Matias, Ana T.
    Braga, Sofia
    Jacinto, Antonio
    Cabral, M. Guadalupe
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [32] Combined histone deacetylase and proteasome inhibition in patient-derived endometrial cancer organoid models promotes massive cell death.
    Bi, Jianling
    Thiel, Kristina W.
    Devor, Eric J.
    Newtson, Andreea M.
    Zhang, Yuping
    Leslie, Kimberly K.
    CLINICAL CANCER RESEARCH, 2021, 27 (03)
  • [33] Co-culture platform for tuning of cancer receptor density allows for evaluation of bispecific immune cell engagers
    Mebrahtu, Aman
    Aniander, Gustav
    Mega, Alessandro
    Barzadd, Mona Moradi
    Thalen, Niklas Berndt
    Gudmundsdotter, Lindvi
    Rydin, Eva Backstrom
    Sandegren, Anna
    Frejd, Fredrik Y.
    Rockberg, Johan
    NEW BIOTECHNOLOGY, 2024, 79 : 120 - 126
  • [34] EXPLORATION OF RESISTANCE OF PARP INHIBITOR THERAPY IN HIGH-GRADE SEROUS OVARIAN CANCER PATIENT-DERIVED XENOGRAFTS.
    Ye, L.
    Topp, M.
    Boehm, E.
    Hadley, A.
    Cook, M.
    Heong, V.
    Pyman, J.
    McNally, O.
    Ananda, S.
    Harrell, M.
    Alsop, K.
    Bowtell, D. D.
    Johnson, N.
    Kaufmann, S. H.
    Swisher, E. M.
    Wakefield, M.
    Scott, C. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 407 - 408
  • [35] The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells
    Theriault, Brigitte L.
    Cybulska, Paulina
    Shaw, Patricia A.
    Gallie, Brenda L.
    Bernardini, Marcus Q.
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [36] Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
    Brittney S Harrington
    Yaowu He
    Claire M Davies
    Sarah J Wallace
    Mark N Adams
    Elizabeth A Beaven
    Deborah K Roche
    Catherine Kennedy
    Naven P Chetty
    Alexander J Crandon
    Christopher Flatley
    Niara B Oliveira
    Catherine M Shannon
    Anna deFazio
    Anna V Tinker
    C Blake Gilks
    Brian Gabrielli
    Donal J Brennan
    Jermaine I Coward
    Jane E Armes
    Lewis C Perrin
    John D Hooper
    British Journal of Cancer, 2016, 114 : 417 - 426
  • [37] The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells
    Brigitte L Thériault
    Paulina Cybulska
    Patricia A Shaw
    Brenda L Gallie
    Marcus Q Bernardini
    Journal of Ovarian Research, 7
  • [38] Establishment and analysis of patient-derived high-grade serous ovarian cancer organoids for disease modeling and drug testing
    Kallunki, Tuula
    Lauridsen, Anna R.
    Skorda, Aikaterini
    Lahtinen, Alexandra
    Bay, Marie L.
    Rasmussen, Benita
    Huhtinen, Kaisa
    Muranen, Taru
    Oikkonen, Jaana
    Hynninen, Johanna
    Hautaniemi, Sampsa
    CANCER RESEARCH, 2024, 84 (06)
  • [39] Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
    Harrington, Brittney S.
    He, Yaowu
    Davies, Claire M.
    Wallace, Sarah J.
    Adams, Mark N.
    Beaven, Elizabeth A.
    Roche, Deborah K.
    Kennedy, Catherine
    Chetty, Naven P.
    Crandon, Alexander J.
    Flatley, Christopher
    Oliveira, Niara B.
    Shannon, Catherine M.
    deFazio, Anna
    Tinker, Anna V.
    Gilks, C. Blake
    Gabrielli, Brian
    Brennan, Donal J.
    Coward, Jermaine I.
    Armes, Jane E.
    Perrin, Lewis C.
    Hooper, John D.
    BRITISH JOURNAL OF CANCER, 2016, 114 (04) : 417 - 426
  • [40] Identification of novel colorectal cancer targets using patient-derived organoid/natural killer cell co-cultures
    von Kries, A.
    Balzasch, B.
    Betge, J.
    Burgermeister, E.
    Ebert, M.
    Boutros, M.
    Cerwenka, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 289 - 290
12345